Global Nonalcoholic Steatohepatitis (Nash) Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

December 2023 | 112 pages | ID: G12ED2DD9966EN
Maia Research

Abstracts

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Nonalcoholic Steatohepatitis (Nash) market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Nonalcoholic Steatohepatitis (Nash) market are covered in Chapter 9:
AstraZeneca
Verva Pharmaceuticals
Gilead Science
Nimbus Therapeutics
Novo Nordisk
Boehringer Ingelheim
Viking Therapeutics
Enzo Biochem, Inc
Intercepts Pharmaceuticals
Genfit
Islet Sciences
In Chapter 5 and Chapter 7.3, based on types, the Nonalcoholic Steatohepatitis (Nash) market from 2017 to 2027 is primarily split into:
Vitamin E & Pioglitazone
Ocaliva
Elafibranor
Selonsertib & Cenicriviroc
In Chapter 6 and Chapter 7.4, based on applications, the Nonalcoholic Steatohepatitis (Nash) market from 2017 to 2027 covers:
Hospitals
Clinics
Homecare Settings
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Nonalcoholic Steatohepatitis (Nash) market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Nonalcoholic Steatohepatitis (Nash) Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027

Contents

1 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (Nash) Market
1.2 Nonalcoholic Steatohepatitis (Nash) Market Segment by Type
  1.2.1 Global Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Nonalcoholic Steatohepatitis (Nash) Market Segment by Application
  1.3.1 Nonalcoholic Steatohepatitis (Nash) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Nonalcoholic Steatohepatitis (Nash) Market, Region Wise (2017-2027)
  1.4.1 Global Nonalcoholic Steatohepatitis (Nash) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
  1.4.3 Europe Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
  1.4.4 China Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
  1.4.5 Japan Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
  1.4.6 India Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
  1.4.8 Latin America Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Nonalcoholic Steatohepatitis (Nash) (2017-2027)
  1.5.1 Global Nonalcoholic Steatohepatitis (Nash) Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Nonalcoholic Steatohepatitis (Nash) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Nonalcoholic Steatohepatitis (Nash) Market

2 INDUSTRY OUTLOOK

2.1 Nonalcoholic Steatohepatitis (Nash) Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Nonalcoholic Steatohepatitis (Nash) Market Drivers Analysis
2.4 Nonalcoholic Steatohepatitis (Nash) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Nonalcoholic Steatohepatitis (Nash) Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Nonalcoholic Steatohepatitis (Nash) Industry Development

3 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET LANDSCAPE BY PLAYER

3.1 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Share by Player (2017-2022)
3.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Market Share by Player (2017-2022)
3.3 Global Nonalcoholic Steatohepatitis (Nash) Average Price by Player (2017-2022)
3.4 Global Nonalcoholic Steatohepatitis (Nash) Gross Margin by Player (2017-2022)
3.5 Nonalcoholic Steatohepatitis (Nash) Market Competitive Situation and Trends
  3.5.1 Nonalcoholic Steatohepatitis (Nash) Market Concentration Rate
  3.5.2 Nonalcoholic Steatohepatitis (Nash) Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19
4.5 Europe Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19
4.6 China Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19
4.7 Japan Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19
4.8 India Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19
4.9 Southeast Asia Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19
4.10 Latin America Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19
4.11 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Under COVID-19

5 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Market Share by Type (2017-2022)
5.3 Global Nonalcoholic Steatohepatitis (Nash) Price by Type (2017-2022)
5.4 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue and Growth Rate of Vitamin E & Pioglitazone (2017-2022)
  5.4.2 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue and Growth Rate of Ocaliva (2017-2022)
  5.4.3 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue and Growth Rate of Elafibranor (2017-2022)
  5.4.4 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue and Growth Rate of Selonsertib & Cenicriviroc (2017-2022)

6 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY APPLICATION

6.1 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Market Share by Application (2017-2022)
6.2 Global Nonalcoholic Steatohepatitis (Nash) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Hospitals (2017-2022)
  6.3.2 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Clinics (2017-2022)
  6.3.3 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Homecare Settings (2017-2022)

7 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST (2022-2027)

7.1 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Nonalcoholic Steatohepatitis (Nash) Price and Trend Forecast (2022-2027)
7.2 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Growth Rate of Vitamin E & Pioglitazone (2022-2027)
  7.3.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Growth Rate of Ocaliva (2022-2027)
  7.3.3 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Growth Rate of Elafibranor (2022-2027)
  7.3.4 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Growth Rate of Selonsertib & Cenicriviroc (2022-2027)
7.4 Global Nonalcoholic Steatohepatitis (Nash) Consumption Forecast by Application (2022-2027)
  7.4.1 Global Nonalcoholic Steatohepatitis (Nash) Consumption Value and Growth Rate of Hospitals(2022-2027)
  7.4.2 Global Nonalcoholic Steatohepatitis (Nash) Consumption Value and Growth Rate of Clinics(2022-2027)
  7.4.3 Global Nonalcoholic Steatohepatitis (Nash) Consumption Value and Growth Rate of Homecare Settings(2022-2027)
7.5 Nonalcoholic Steatohepatitis (Nash) Market Forecast Under COVID-19

8 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Nonalcoholic Steatohepatitis (Nash) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Nonalcoholic Steatohepatitis (Nash) Analysis
8.6 Major Downstream Buyers of Nonalcoholic Steatohepatitis (Nash) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Nonalcoholic Steatohepatitis (Nash) Industry

9 PLAYERS PROFILES

9.1 AstraZeneca
  9.1.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.1.3 AstraZeneca Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Verva Pharmaceuticals
  9.2.1 Verva Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.2.3 Verva Pharmaceuticals Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Gilead Science
  9.3.1 Gilead Science Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.3.3 Gilead Science Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Nimbus Therapeutics
  9.4.1 Nimbus Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.4.3 Nimbus Therapeutics Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Novo Nordisk
  9.5.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.5.3 Novo Nordisk Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Boehringer Ingelheim
  9.6.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.6.3 Boehringer Ingelheim Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Viking Therapeutics
  9.7.1 Viking Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.7.3 Viking Therapeutics Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Enzo Biochem, Inc
  9.8.1 Enzo Biochem, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.8.3 Enzo Biochem, Inc Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Intercepts Pharmaceuticals
  9.9.1 Intercepts Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.9.3 Intercepts Pharmaceuticals Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Genfit
  9.10.1 Genfit Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.10.3 Genfit Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Islet Sciences
  9.11.1 Islet Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Nonalcoholic Steatohepatitis (Nash) Product Profiles, Application and Specification
  9.11.3 Islet Sciences Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES




Figure Nonalcoholic Steatohepatitis (Nash) Product Picture

Table Global Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and CAGR (%) Comparison by Type

Table Nonalcoholic Steatohepatitis (Nash) Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Nonalcoholic Steatohepatitis (Nash) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Nonalcoholic Steatohepatitis (Nash) Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Nonalcoholic Steatohepatitis (Nash) Industry Development

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume by Player (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Share by Player (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Share by Player in 2021

Table Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) by Player (2017-2022)

Table Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Player (2017-2022)

Table Nonalcoholic Steatohepatitis (Nash) Price by Player (2017-2022)

Table Nonalcoholic Steatohepatitis (Nash) Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Region Wise (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Market Share, Region Wise in 2021

Table Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD), Region Wise (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share, Region Wise (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share, Region Wise (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share, Region Wise in 2021

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume by Type (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Market Share by Type (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Market Share by Type in 2021

Table Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) by Type (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Type (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Type in 2021

Table Nonalcoholic Steatohepatitis (Nash) Price by Type (2017-2022)

Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate of Vitamin E & Pioglitazone (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Vitamin E & Pioglitazone (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate of Ocaliva (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Ocaliva (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate of Elafibranor (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Elafibranor (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate of Selonsertib & Cenicriviroc (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Selonsertib & Cenicriviroc (2017-2022)
Table Global Nonalcoholic Steatohepatitis (Nash) Consumption by Application (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Consumption Market Share by Application (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Consumption Revenue Market Share by Application (2017-2022)

Table Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Clinics (2017-2022)
Table Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Homecare Settings (2017-2022)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Nonalcoholic Steatohepatitis (Nash) Price and Trend Forecast (2022-2027)

Figure USA Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Nonalcoholic Steatohepatitis (Nash) Market Sales Volume Forecast, by Type

Table Global Nonalcoholic Steatohepatitis (Nash) Sales Volume Market Share Forecast, by Type

Table Global Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) Forecast, by Type

Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share Forecast, by Type

Table Global Nonalcoholic Steatohepatitis (Nash) Price Forecast, by Type

Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Vitamin E & Pioglitazone (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Vitamin E & Pioglitazone (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Ocaliva (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Ocaliva (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Elafibranor (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Elafibranor (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Selonsertib & Cenicriviroc (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (Million USD) and Growth Rate of Selonsertib & Cenicriviroc (2022-2027)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Consumption Forecast, by Application

Table Global Nonalcoholic Steatohepatitis (Nash) Consumption Market Share Forecast, by Application

Table Global Nonalcoholic Steatohepatitis (Nash) Market Revenue (Million USD) Forecast, by Application

Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share Forecast, by Application

Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption Value (Million USD) and Growth Rate of Homecare Settings (2022-2027)
Figure Nonalcoholic Steatohepatitis (Nash) Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table AstraZeneca Profile
Table AstraZeneca Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table Verva Pharmaceuticals Profile
Table Verva Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Verva Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Gilead Science Profile
Table Gilead Science Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gilead Science Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Gilead Science Revenue (Million USD) Market Share 2017-2022
Table Nimbus Therapeutics Profile
Table Nimbus Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Nimbus Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk Profile
Table Novo Nordisk Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Novo Nordisk Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Viking Therapeutics Profile
Table Viking Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Viking Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Enzo Biochem, Inc Profile
Table Enzo Biochem, Inc Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Enzo Biochem, Inc Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Enzo Biochem, Inc Revenue (Million USD) Market Share 2017-2022
Table Intercepts Pharmaceuticals Profile
Table Intercepts Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Intercepts Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Intercepts Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Genfit Profile
Table Genfit Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genfit Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Genfit Revenue (Million USD) Market Share 2017-2022
Table Islet Sciences Profile
Table Islet Sciences Nonalcoholic Steatohepatitis (Nash) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Islet Sciences Nonalcoholic Steatohepatitis (Nash) Sales Volume and Growth Rate
Figure Islet Sciences Revenue (Million USD) Market Share 2017-2022